Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-03 4:38 pm Unchanged | 2026-08-03 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 14,134,481 83.900% | 0 (Unchanged) | Filing History |
| 2026-07-28 7:51 pm Purchase | 2026-07-23 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Unleash Immuno Oncolytics, Inc. | 300,000 9.940% | 300,000 (New Position) | Filing History |
| 2026-07-28 7:50 pm Purchase | 2026-07-23 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Elena Rosa Braci | 186,236 6.170% | 186,236 (New Position) | Filing History |
| 2026-07-28 7:48 pm Purchase | 2026-07-23 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Daniel Eduardo Katzman | 155,611 5.160% | 155,611 (New Position) | Filing History |
| 2026-07-27 4:15 pm Purchase | 2026-07-27 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 14,134,481 83.900% | 13,834,441 (+4610.87%) | Filing History |
| 2026-07-23 4:15 pm Purchase | 2026-07-23 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 300,040 9.900% | 216,755 (+260.26%) | Filing History |
| 2026-07-17 4:15 pm Unchanged | 2026-07-17 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 8.800% | 0 (Unchanged) | Filing History |
| 2026-04-20 4:56 pm Purchase | 2026-04-15 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | YA II PN Ltd. | 101,772 9.900% | 101,772 (New Position) | Filing History |
| 2026-01-07 12:38 pm Purchase | 2025-12-31 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | SABBY MANAGEMENT LLC | 41,601 4.900% | 39,117 (+1574.76%) | Filing History |
| 2025-11-10 2:16 pm Sale | 2025-09-30 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | GOLDMAN SACHS GROUP INC GS | 82 0.000% | -48,936 (-99.83%) | Filing History |
| 2025-10-28 5:39 pm Unchanged | 2025-10-27 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 9.100% | 0 (Unchanged) | Filing History |
| 2025-10-16 4:05 pm Purchase | 2025-10-08 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | CK Life Sciences Intl (Holdings) Inc | 83,285 9.100% | 83,285 (New Position) | Filing History |
| 2025-08-14 9:55 pm Purchase | 2025-06-30 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Anson Funds Management LP | 27,125 0.100% | 23,072 (+569.26%) | Filing History |
| 2025-08-14 2:16 pm Purchase | 2025-06-30 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | GOLDMAN SACHS GROUP INC GS | 49,018 5.900% | 49,018 (New Position) | Filing History |
| 2025-03-20 5:16 pm Purchase | 2025-03-07 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Thomas Joseph Tracy | 1,250 5.000% | 1,250 (New Position) | Filing History |
| 2025-02-14 5:16 pm Purchase | 2024-12-31 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | Anson Funds Management LP | 4,053 9.900% | 4,053 (New Position) | Filing History |
| 2025-01-03 7:25 pm Purchase | 2024-12-31 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | SABBY MANAGEMENT LLC | 2,484 9.900% | 2,484 (New Position) | Filing History |
| 2024-11-06 4:05 pm Sale | 2024-09-30 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | 3i, LP | 0 0.000% | -1,858 (Position Closed) | Filing History |
| 2024-07-26 4:05 pm Purchase | 2024-07-23 | 13G | TRANSCODE THERAPEUTICS INC RNAZ | 3i, LP | 1,858 9.900% | 1,858 (New Position) | Filing History |
| 2024-06-21 4:02 pm Purchase | 2024-06-14 | 13D | TRANSCODE THERAPEUTICS INC RNAZ | Fitzgerald Thomas A | 457 5.500% | 457 (New Position) | Filing History |